BACE1-IN-13

Modify Date: 2024-01-28 11:04:17

BACE1-IN-13 structure	Common Name	BACE1-IN-13
	CAS Number	1397683-26-9	Molecular Weight	420.40
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₂₀H₁₇FN₈O₂	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of BACE1-IN-13

BACE1-IN-13 (Compound 36) is an orally active BACE1 inhibitor with an IC50 value of 2.9 nM. BACE1-IN-13 is highly potent in hAβ42 cell (IC50 = 1.3 nM). BACE1-IN-13 has cardiovascularly safty and elicits sustained Aβ42 reduction in mouse and dog animal models[1].

Name	BACE1-IN-13

Description	BACE1-IN-13 (Compound 36) is an orally active BACE1 inhibitor with an IC50 value of 2.9 nM. BACE1-IN-13 is highly potent in hAβ42 cell (IC50 = 1.3 nM). BACE1-IN-13 has cardiovascularly safty and elicits sustained Aβ42 reduction in mouse and dog animal models[1].
Related Catalog	Signaling Pathways >> Neuronal Signaling >> Beta-secretase Research Areas >> Neurological Disease
Target	IC50: 1.3 nM (hAβ42 cell)[1].
References	[1]. Peschiulli A, et al. A Brain-Penetrant and Bioavailable Pyrazolopiperazine BACE1 Inhibitor Elicits Sustained Reduction of Amyloid β In Vivo. ACS Med Chem Lett. 2021 Dec 1;13(1):76-83.

Molecular Formula	C₂₀H₁₇FN₈O₂
Molecular Weight	420.40

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.

BACE1-IN-13

Use of BACE1-IN-13

Names

BACE1-IN-13 Biological Activity

Chemical & Physical Properties

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.